Brief: Bioretec Receives FDA Approval For Bioresorbable Metal Product
30/03/2023 06:52
March 30 (Reuters) - Bioretec Oy BRETEC.HE :
* BIORETEC IS THE FIRST IN THE WORLD TO RECEIVE FDA APPROVAL
FOR A
BIORESORBABLE METAL PRODUCT
* BIORETEC IS FIRST AND CURRENTLY, ONLY MEDICAL DEVICE
COMPANY TO
OFFER BIORESORBABLE METAL IMPLANTS IN UNITED STATES
* FDA MARKET AUTHORIZATION ENABLES SALE AND MARKETING OF
REMEOS™
TRAUMA SCREW IN SEVERAL OTHER COUNTRIES
Source text for Eikon: ID:nWkr58ghNq
Further company coverage: BRETEC.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million